Anthropic's IPO is drawing far more demand than expected. On November 11, Bloomberg reported, citing people familiar with the matter, that the Claude developer's initial public offering has attracted orders several times the number of shares on offer, with the book already covered across the $70–$78 price range on the first day of the roadshow. At the top of the range, the public offering plus a concurrent private placement could raise as much as $90.4 billion, which would pass SpaceX as the largest listing in history.
Anthropic plans to sell 825 million Class A shares, raising about $64.4 billion at the top of the range. Seven chip and cloud companies — Google, Nvidia, AMD, Broadcom, Micron, Microsoft and TSMC — will buy $26 billion of non-voting stock at the IPO price in a concurrent private placement, with Google and Nvidia each investing $10 billion. Goldman Sachs and Morgan Stanley are leading a syndicate of 22 banks; the shares are set to trade on the Nasdaq Global Select Market under the ticker ANT, with pricing expected on the evening of November 18 and trading to begin on November 19. On the business side, Anthropic's revenue reached $33.2 billion in the first nine months of the year, up 1,206% year on year, and run-rate revenue stood at about $81 billion at the end of October, up roughly $10 billion in a single month.
The demand is real, and so are the open questions
Heavy demand does not mean the deal is done. Indications of interest are not binding, final pricing and allocations will only be set on November 18, and the price range can still move. The Financial Times reported that the underwriters are considering pricing above the range, taking the valuation back to $1.5 trillion or more, but no filing has been amended, so that remains unconfirmed. The valuation yardstick matters too: the roughly $1.4 trillion figure is fully diluted, counting stock options and restricted shares, while the value based only on shares outstanding after the offering is about $1 trillion. The plan for each of the seven co-founders to sell about $250 million of stock is unchanged, and control stays with the founders.
Three things to watch next: whether final pricing on November 18 breaks above the range, whether the retail allocation reaches the rumored level of about 20%, and whether the share price on the November 19 debut can support a $1.4 trillion fully diluted valuation. For ordinary investors, an order book covered several times over is a signal of heat, not a guarantee of gains; the real test of this record-breaking IPO comes once pricing and allocations are known.
